Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.671,64
1,24%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Magenta Therapeutics Inc (MGTA) Magenta Therapeutics Inc (MGTA) Notizie

Magenta Therapeutics Inc

MGTA
11,1936
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/4/202422:10EDGAR2Form ARS - Annual Report to Security Holders
11/4/202422:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/4/202422:05EDGAR2Form DEF 14A - Other definitive proxy statements
02/4/202400:34EDGAR2Form SC 13D/A - General statement of acquisition of..
02/4/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/3/202422:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/3/202422:02EDGAR2Form S-1/A - General form for registration of securities..
21/3/202421:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/3/202421:04EDGAR2Form 8-K - Current report
14/2/202422:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202422:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202422:52EDGAR2Form S-1/A - General form for registration of securities..
02/2/202422:32EDGAR2Form SC 13G - Statement of acquisition of beneficial..
31/1/202418:11EDGAR2Form SC 13D - General statement of acquisition of beneficial..
26/1/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202423:26EDGAR2Form SC 13D/A - General statement of acquisition of..
22/1/202413:34EDGAR2Form 8-K - Current report
08/1/202414:02EDGAR2Form 8-K - Current report
21/12/202323:08EDGAR2Form S-1/A - General form for registration of securities..
21/12/202322:16EDGAR2Form 8-K - Current report
09/11/202322:09EDGAR2Form 8-K - Current report
25/10/202322:15EDGAR2Form 8-K - Current report
04/10/202322:55EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/10/202322:20EDGAR2Form S-3 - Registration statement under Securities Act of..
25/9/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202322:34EDGAR2Form SC 13D - General statement of acquisition of beneficial..
21/9/202322:32EDGAR2Form SC 13D - General statement of acquisition of beneficial..
21/9/202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/9/202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/9/202303:50EDGAR2Form 8-K/A - Current report: [Amend]
14/9/202303:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202303:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/9/202303:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202303:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202303:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202302:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/9/202302:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/9/202302:48EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/9/202302:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/9/202302:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/9/202322:05EDGAR2Form 8-K - Current report
08/9/202323:19EDGAR2Form 8-K - Current report
31/8/202315:00EDGAR2Form 425 - Prospectuses and communications, business..
03/8/202314:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202322:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/7/202315:30EDGAR2Form S-4/A - Registration of securities, business..
Apertura: Min: Max:
Chiusura: 11,1936

La tua Cronologia

NASDAQ
MGTA
Magenta Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network